Chapter 4 Replication and Partitioning of Papillomavirus Genomes

Advances in Virus Research

Volumn 72, Issue , 2008, Pages 155-205

  McBride, Alison A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

DNA REPLICATION; GENETICS; PAPILLOMA VIRUS; PHYSIOLOGY; REVIEW; VIRUS GENOME; VIRUS REPLICATION;

DNA REPLICATION; DNA, VIRAL; GENOME, VIRAL; PAPILLOMAVIRIDAE; VIRUS REPLICATION;

EID: 57149092794     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/S0065-3527(08)00404-1     Document Type: Review

References (276)

1. Abbate E.A., Berger J.M., and Botchan M.R. The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Genes Dev. 18 (2004) 1981-1996
2. Abbate E.A., Voitenleitner C., and Botchan M.R. Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association. Mol. Cell 24 (2006) 877-889
3. Abroi A., Kurg R., and Ustav M. Transcriptional and replicational activation functions in the BPV1 E2 protein are encoded by different structural determinants. J. Virol. 70 (1996) 6169-6179
4. Abroi A., Ilves I., Kivi S., and Ustav M. Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein. J. Virol. 78 (2004) 2100-2113
5. Ai W., Toussaint E., and Roman A. CCAAT displacement protein binds to and negatively regulates human papillomavirus type 6 E6, E7, and E1 promoters. J. Virol. 73 (1999) 4220-4229
6. Akgul B., Karle P., Adam M., Fuchs P.G., and Pfister H.J. Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8. Virology 308 (2003) 279-290
7. Androphy E.J., Lowy D.R., and Schiller J.T. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 325 (1987) 70-73
8. Angeletti P.C., Kim K., Fernandes F.J., and Lambert P.F. Stable replication of papillomavirus genomes in Saccharomyces cerevisiae. J. Virol. 76 (2002) 3350-3358
9. Antson A.A., Burns J.E., Moroz O.V., Scott D.J., Sanders C.M., Bronstein I.B., Dodson G.G., Wilson K.S., and Maitland N.J. Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 403 (2000) 805-809
10. Ashrafi G.H., Brown D.R., Fife K.H., and Campo M.S. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res. 120 (2006) 208-211
11. Auster A.S., and Joshua-Tor L. The DNA-binding domain of human papillomavirus type 18 E1. Crystal structure, dimerization, and DNA binding. J. Biol. Chem. 279 (2004) 3733-3742
12. Baiker A., Maercker C., Piechaczek C., Schmidt S.B., Bode J., Benham C., and Lipps H.J. Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix. Nat. Cell Biol. 2 (2000) 182-184
13. Barbera A.J., Chodaparambil J.V., Kelley-Clarke B., Joukov V., Walter J.C., Luger K., and Kaye K.M. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311 (2006) 856-861
14. Barsoum J., Prakash S.S., Han P., and Androphy E.J. Mechanism of action of the papillomavirus E2 repressor: Repression in the absence of DNA binding. J. Virol. 66 (1992) 3941-3945
15. Bastien N., and McBride A.A. Interaction of the papillomavirus E2 with mitotic chromosomes. Virology 270 (2000) 124-134
16. Baxter M.K., McPhillips M.G., Ozato K., and McBride A.A. The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J. Virol. 79 (2005) 4806-4818
17. Bedell M.A., Hudson J.B., Golub T.R., Turyk M.E., Hosken M., Wilbanks G.D., and Laimins L.A. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65 (1991) 2254-2260
18. Bedrosian C.L., and Bastia D. The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: Protein-induced DNA bending and role of the nonconserved core sequence in binding site affinity. Virology 174 (1990) 557-575
19. Bellanger S., Demeret C., Goyat S., and Thierry F. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 75 (2001) 7244-7251
20. Berg L., Lusky M., Stenlund A., and Botchan M.R. Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor. Cell 46 (1986) 753-762
21. Bernard B.A., Bailly C., Lenoir M.C., Darmon M., Thierry F., and Yaniv M. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol. 63 (1989) 4317-4324
22. Bernard H.U., Calleja-Macias I.E., and Dunn S.T. Genome variation of human papillomavirus types: Phylogenetic and medical implications. Int. J. Cancer 118 (2006) 1071-1076
23. Bian X.L., Rosas-Acosta G., Wu Y.C., and Wilson V.G. Nuclear import of bovine papillomavirus type 1 E1 protein is mediated by multiple alpha importins and is negatively regulated by phosphorylation near a nuclear localization signal. J. Virol. 81 (2007) 2899-2908
24. Bochkarev A., Barwell J.A., Pfuetzner R.A., Furey W.J., Edwards A.M., and Frappier L. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1. Cell 83 (1995) 39-46
25. Borowiec J.A., Dean F.B., Bullock P.A., and Hurwitz J. Binding and unwinding--how T antigen engages the SV40 origin of DNA replication. Cell 60 (1990) 181-184
26. Botchan M., Berg L., Reynolds J., and Lusky M. The bovine papillomavirus replicon. Ciba Found. Symp. 120 (1986) 53-67
27. Bousarghin L., Touze A., Sizaret P.Y., and Coursaget P. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 77 (2003) 3846-3850
28. Brannon A.R., Maresca J.A., Boeke J.D., Basrai M.A., and McBride A.A. Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein. Proc. Natl. Acad. Sci. USA 102 (2005) 2998-3003
29. Brokaw J.L., Blanco M., and McBride A.A. Amino acids critical for the functions of the bovine papillomavirus type 1 E2 transactivator. J. Virol. 70 (1996) 23-29
30. Brown C., Kowalczyk A.M., Taylor E.R., Morgan I.M., and Gaston K. p53 represses human papillomavirus type 16 DNA replication via the viral E2 protein. Virol. J. 5 (2008) 5
31. Brown D.R., Kitchin D., Qadadri B., Neptune N., Batteiger T., and Ermel A. The human papillomavirus type 11 E1--E4 protein is a transglutaminase 3 substrate and induces abnormalities of the cornified cell envelope. Virology 345 (2006) 290-298
32. Burnett S., Strom A.C., Jareborg N., Alderborn A., Dillner J., Moreno-Lopez J., Pettersson U., and Kiessling U. Induction of bovine papillomavirus E2 gene expression and early region transcription by cell growth arrest: Correlation with viral DNA amplification and evidence for differential promoter induction. J. Virol. 64 (1990) 5529-5541
33. Calderwood M.A., Hall K.T., Matthews D.A., and Whitehouse A. The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus. J. Gen. Virol. 85 (2004) 147-153
34. Cardenas-Mora J., Spindler J.E., Jang M.K., and McBride A.A. Dimerization of the Papillomavirus E2 Protein is Required for Efficient Mitotic Chromosome Association and Brd4 Binding. J. Virol. 82 (2008) 7298-7305
35. Castella S., Bingham G., and Sanders C.M. Common determinants in DNA melting and helicase-catalysed DNA unwinding by papillomavirus replication protein E1. Nucleic Acids Res. 34 (2006) 3008-3019
36. Chatterjee A., Freeman J.W., and Busch H. Identification and partial characterization of a Mr 40,000 nucleolar antigen associated with cell proliferation. Cancer Res. 47 (1987) 1123-1129
37. Chattopadhyay A., Schmidt M.C., and Khan S.A. Identification of a 450-bp region of human papillomavirus type 1 that promotes episomal replication in Saccharomyces cerevisiae. Virology 340 (2005) 133-142
38. Chaudhuri B., Xu H., Todorov I., Dutta A., and Yates J.L. Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 98 (2001) 10085-10089
39. Chen G., and Stenlund A. Characterization of the DNA-binding domain of the bovine papillomavirus replication initiator E1. J. Virol. 72 (1998) 2567-2576
40. Chen G., and Stenlund A. The E1 initiator recognizes multiple overlapping sites in the papillomavirus origin of DNA replication. J. Virol. 75 (2001) 292-302
41. Chiang C.M., Dong G., Broker T.R., and Chow L.T. Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins. J. Virol. 66 (1992) 5224-5231
42. Choe J., Vaillancourt P., Stenlund A., and Botchan M. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: Structural and functional analysis of new viral cDNAs. J. Virol. 63 (1989) 1743-1755
43. Clower R.V., Fisk J.C., and Melendy T. Papillomavirus E1 protein binds to and stimulates human topoisomerase I. J. Virol. 80 (2006) 1584-1587
44. Conger K.L., Liu J.S., Kuo S.R., Chow L.T., and Wang T.S. Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human dna polymerase alpha/primase. J. Biol. Chem. 274 (1999) 2696-2705
45. Cotter M.A., and Robertson E.S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma- associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264 (1999) 254-264
46. Cripe T.P., Haugen T.H., Turk J.P., Tabatabai F., Schmid P.G., Dürst M., Gissmann L., Roman A., and Turek L.P. Transcriptional regulation of the human papillomavirus- 16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: Implications for cervical carcinogenesis. EMBO J 6 (1987) 3745-3753
47. Cueille N., Nougarede R., Mechali F., Philippe M., and Bonne-Andrea C. Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2. J. Virol. 72 (1998) 7255-7262
48. Culp T.D., Budgeon L.R., Marinkovich M.P., Meneguzzi G., and Christensen N.D. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J. Virol. 80 (2006) 8940-8950
49. D'Amours D., Stegmeier F., and Amon A. Cdc14 and condensin control the dissolution of cohesin-independent chromosome linkages at repeated DNA. Cell 117 (2004) 455-469
50. Dao L.D., Duffy A., Van Tine B.A., Wu S.Y., Chiang C.M., Broker T.R., and Chow L.T. Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus. J. Virol. 80 (2006) 4792-4800
51. Dasgupta S., Zabielski J., Simonsson M., and Burnett S. Rolling-circle replication of a high-copy BPV-1 plasmid. J. Mol. Biol. 228 (1992) 1-6
52. Davy C.E., Jackson D.J., Wang Q., Raj K., Masterson P.J., Fenner N.F., Southern S., Cuthill S., Millar J.B., and Doorbar J. Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J. Virol. 76 (2002) 9806-9818
53. Day P.M., Baker C.C., Lowy D.R., and Schiller J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. USA 101 (2004) 14252-14257
54. Day P.M., Lowy D.R., and Schiller J.T. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307 (2003) 1-11
55. Day P.M., Roden R.B., Lowy D.R., and Schiller J.T. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J. Virol. 72 (1998) 142-150
56. DeMasi J., Huh K.W., Nakatani Y., Munger K., and Howley P.M. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proc. Natl. Acad. Sci. USA 102 (2005) 11486-11491
57. Deng W., Lin B.Y., Jin G., Wheeler C.G., Ma T., Harper J.W., Broker T.R., and Chow L.T. Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase. J. Virol. 78 (2004) 13954-13965
58. Deng Z., Atanasiu C., Burg J.S., Broccoli D., and Lieberman P.M. Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J. Virol. 77 (2003) 11992-12001
59. Deng Z., Lezina L., Chen C.J., Shtivelband S., So W., and Lieberman P.M. Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol. Cell 9 (2002) 493-503
60. Dey A., Chitsaz F., Abbasi A., Misteli T., and Ozato K. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl. Acad. Sci. USA 100 (2003) 8758-8763
61. Dey A., Ellenberg J., Farina A., Coleman A.E., Maruyama T., Sciortino S., Lippincott-Schwartz J., and Ozato K. A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol. Cell Biol. 20 (2000) 6537-6549
62. DiMaio D., and Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20 (2001) 7866-7873
63. Donaldson M.M., Boner W., and Morgan I.M. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J. Virol. 81 (2007) 4338-4342
64. Doorbar J., Ely S., Sterling J., McLean C., and Crawford L. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352 (1991) 824-827
65. Dowhanick J.J., McBride A.A., and Howley P.M. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69 (1995) 7791-7799
66. Enemark E.J., Chen G., Vaughn D.E., Stenlund A., and Joshua-Tor L. Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus. Mol. Cell 6 (2000) 149-158
67. Enemark E.J., and Joshua-Tor L. Mechanism of DNA translocation in a replicative hexameric helicase. Nature 442 (2006) 270-275
68. Evander M., Frazer I.H., Payne E., Qi Y.M., Hengst K., and McMillan N.A. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J. Virol. 71 (1997) 2449-2456
69. Evans M.F., Aliesky H.A., and Cooper K. Optimization of biotinyl-tyramide-based in situ hybridization for sensitive background-free applications on formalin-fixed, paraffin-embedded tissue specimens. BMC. Clin. Pathol. 3 (2003) 2
70. Fabunmi R.P., Wigley W.C., Thomas P.J., and DeMartino G.N. Activity and regulation of the centrosome-associated proteasome. J. Biol. Chem. 275 (2000) 409-413
71. Favre M., Breitburd F., Croissant O., and Orth G. Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses. J. Virol. 21 (1977) 1205-1209
72. Ferran M.C., and McBride A.A. Transient viral DNA replication and repression of viral transcription are supported by the C-terminal domain of the bovine papillomavirus type 1 E1 protein. J. Virol. 72 (1998) 796-801
73. Florence B., and Faller D.V. You bet-cha: A novel family of transcriptional regulators. Front Biosci. 6 (2001) D1008-D1018
74. Flores E.R., Allen-Hoffmann B.L., Lee D., Sattler C.A., and Lambert P.F. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology 262 (1999) 344-354
75. Flores E.R., and Lambert P.F. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J. Virol. 71 (1997) 7167-7179
76. Fradet-Turcotte A., and Archambault J. Recent advances in the search for antiviral agents against human papillomaviruses. Antivir. Ther. 12 (2007) 431-451
77. Frattini M.G., Hurst S.D., Lim H.B., Swaminathan S., and Laimins L.A. Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. EMBO J. 16 (1997) 318-331
78. Frattini M.G., Lim H.B., and Laimins L.A. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc. Natl. Acad. Sci. USA 93 (1996) 3062-3067
79. Freeman L., Ragon-Alcaide L., and Strunnikov A. The condensin complex governs chromosome condensation and mitotic transmission of rDNA. J. Cell Biol. 149 (2000) 811-824
80. Friedmann T. Stanfield Rogers: Insights into virus vectors and failure of an early gene therapy model. Mol. Ther. 4 (2001) 285-288
81. Gadi V.K., Zou N., Liu J.S., Cheng S., Broker T.R., Sorscher E.J., and Chow L.T. Components of human papillomavirus that activate transcription and support plasmid replication in human airway cells. Am. J. Respir. Cell Mol. Biol. 20 (1999) 1001-1006
82. Gammoh N., Grm H.S., Massimi P., and Banks L. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J. Virol. 80 (2006) 1787-1797
83. Gilbert D.M. In search of the holy replicator. Nat. Rev. Mol. Cell Biol. 5 (2004) 848-855
84. Gilbert D.M., and Cohen S.N. Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell 50 (1987) 59-68
85. Gillison M.L., and Lowy D.R. A causal role for human papillomavirus in head and neck cancer. Lancet 363 (2004) 1488-1489
86. Giroglou T., Florin L., Schafer F., Streeck R.E., and Sapp M. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 75 (2001) 1565-1570
87. Goodwin E.C., Naeger L.K., Breiding D.E., Androphy E.J., and DiMaio D. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines. J. Virol. 72 (1998) 3925-3934
88. Gopalakrishnan V., and Khan S.A. E1 protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication. Proc. Natl. Acad. Sci. USA 91 (1995) 9597-9601
89. Griffiths R., and Whitehouse A. Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2. J. Virol. 81 (2007) 4021-4032
90. Grundhoff A., and Ganem D. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J. Virol. 77 (2003) 2779-2783
91. Hammerschmidt W., and Sugden B. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55 (1988) 427-433
92. Han Y., Loo Y.M., Militello K.T., and Melendy T. Interactions of the papovavirus DNA replication initiator proteins, bovine papillomavirus type 1 E1 and simian virus 40 large T antigen, with human replication protein A. J. Virol. 73 (1999) 4899-4907
93. Hartley K.A., and Alexander K.A. Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication. J. Virol. 76 (2002) 5014-5023
94. Hegde R.S., Grossman S.R., Laimins L.A., and Sigler P.B. Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA- binding domain bound to its DNA target. Nature 359 (1992) 505-512
95. Hernandez-Ramon E.E., Burns J.E., Zhang W., Walker H.F., Allen S., Antson A.A., and Maitland N.J. Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region. J. Virol. 82 (2008) 4853-4861
96. Hickman A.B., Ronning D.R., Perez Z.N., Kotin R.M., and Dyda F. The nuclease domain of adeno-associated virus rep coordinates replication initiation using two distinct DNA recognition interfaces. Mol. Cell 13 (2004) 403-414
97. Hindmarsh P.L., and Laimins L.A. Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol. J. 4 (2007) 19
98. Hoffmann R., Hirt B., Bechtold V., Beard P., and Raj K. Different modes of human papillomavirus DNA replication during maintenance. J. Virol. 80 (2006) 4431-4439
99. Holt S.E., Schuller G., and Wilson V.G. DNA binding specificity of the bovine papillomavirus E1 protein is determined by sequences contained within an 18-base-pair inverted repeat element at the origin of replication. J. Virol. 68 (1994) 1094-1102
100. Hsu C.Y., Mechali F., and Bonne-Andrea C. Nucleocytoplasmic shuttling of bovine papillomavirus E1 helicase downregulates viral DNA replication in S phase. J. Virol. 81 (2007) 384-394
101. Hubert W.G., and Lambert P.F. The 23-kilodalton E1 phosphoprotein of bovine papillomavirus type 1 is nonessential for stable plasmid replication in murine C127 cells. J. Virol. 67 (1993) 2932-2937
102. Huh K.W., DeMasi J., Ogawa H., Nakatani Y., Howley P.M., and Munger K. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc. Natl. Acad. Sci. USA 102 (2005) 11492-11497
103. Ilves I., Kadaja M., and Ustav M. Two separate replication modes of the bovine papillomavirus BPV1 origin of replication that have different sensitivity to p53. Virus Res. 96 (2003) 75-84
104. Ilves I., Kivi S., and Ustav M. Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which Is mediated by the viral E2 protein and its binding sites. J. Virol. 73 (1999) 4404-4412
105. Ilves I., Maemets K., Silla T., Janikson K., and Ustav M. Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J. Virol. 80 (2006) 3660-3665
106. Ilyina T.V., and Koonin E.V. Conserved sequence motifs in the initiator proteins for rolling circle DNA replication encoded by diverse replicons from eubacteria, eucaryotes and archaebacteria. Nucleic Acids Res. 20 (1992) 3279-3285
107. Jacob F., and Brenner S. [On the regulation of DNA synthesis in bacteria: The hypothesis of the replicon.]. C.R.Hebd. Seances Acad. Sci. 256 (1963) 298-300
108. Jang M.K., Mochizuki K., Zhou M., Jeong H.S., Brady J.N., and Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 19 (2005) 523-534
109. Janin J., Rodier F., Chakrabarti P., and Bahadur R.P. Macromolecular recognition in the Protein Data Bank. Acta Crystallogr. D.Biol. Crystallogr. 63 (2007) 1-8
110. Jeckel S., Huber E., Stubenrauch F., and Iftner T. A transactivator function of cottontail rabbit papillomavirus e2 is essential for tumor induction in rabbits. J. Virol. 76 (2002) 11209-11215
111. Jeckel S., Loetzsch E., Huber E., Stubenrauch F., and Iftner T. Identification of the E9/E2C cDNA and functional characterization of the gene product reveal a new repressor of transcription and replication in cottontail rabbit papillomavirus. J. Virol. 77 (2003) 8736-8744
112. Jenke B.H., Fetzer C.P., Stehle I.M., Jonsson F., Fackelmayer F.O., Conradt H., Bode J., and Lipps H.J. An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo. EMBO Rep. 3 (2002) 349-354
113. Jiang Y.W., Veschambre P., Erdjument-Bromage H., Tempst P., Conaway J.W., Conaway R.C., and Kornberg R.D. Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc Natl. Acad. Sci. USA 95 (1998) 8538-8543
114. Joyce J.G., Tung J.S., Przysiecki C.T., Cook J.C., Lehman E.D., Sands J.A., Jansen K.U., and Keller P.M. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 274 (1999) 5810-5822
115. Kapoor P., and Frappier L. EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes. J. Virol. 77 (2003) 6946-6956
116. Kelley-Clarke B., Ballestas M.E., Komatsu T., and Kaye K.M. Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes. Virology 357 (2007) 149-157
117. Kim K., Angeletti P.C., Hassebroek E.C., and Lambert P.F. Identification of cis-acting elements that mediate the replication and maintenance of human papillomavirus type 16 genomes in Saccharomyces cerevisiae. J. Virol. 79 (2005) 5933-5942
118. Kim K., Garner-Hamrick P.A., Fisher C., Lee D., and Lambert P.F. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol. 77 (2003) 12450-12459
119. Kim K., and Lambert P.F. E1 protein of bovine papillomavirus 1 is not required for the maintenance of viral plasmid DNA replication. Virology 293 (2002) 10-14
120. Kirchmaier A.L., and Sugden B. Rep*: A viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J. Virol. 72 (1998) 4657-4666
121. Kirnbauer R., Booy F., Cheng N., Lowy D.R., and Schiller J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89 (1992) 12180-12184
122. Knight J.D., Li R., and Botchan M. The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops. Proc. Natl. Acad. Sci. USA 88 (1991) 3204-3208
123. Kobayashi T., Heck D.J., Nomura M., and Horiuchi T. Expansion and contraction of ribosomal DNA repeats in Saccharomyces cerevisiae: Requirement of replication fork blocking (Fob1) protein and the role of RNA polymerase I. Genes Dev. 12 (1998) 3821-3830
124. Krithivas A., Fujimuro M., Weidner M., Young D.B., and Hayward S.D. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76 (2002) 11596-11604
125. Kruhlak M.J., Hendzel M.J., Fischle W., Bertos N.R., Hameed S., Yang X.J., Verdin E., and Bazett-Jones D.P. Regulation of global acetylation in mitosis through loss of histone acetyltransferases and deacetylases from chromatin. J. Biol. Chem. 276 (2001) 38307-38319
126. Kuo S.R., Liu J.S., Broker T.R., and Chow L.T. Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts. J. Biol. Chem. 269 (1994) 24058-24065
127. Kurg R., Tekkel H., Abroi A., and Ustav M. Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers. J. Virol. 80 (2006) 11218-11225
128. Lacey C.J. Therapy for genital human papillomavirus-related disease. J. Clin. Virol. 32 (2005) S82-S90
129. Lai M.C., Teh B.H., and Tarn W.Y. A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J. Biol. Chem. 274 (1999) 11832-11841
130. Lambert P.F., Monk B.C., and Howley P.M. Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants. J. Virol. 64 (1990) 950-956
131. Lambert P.F., Spalholz B.A., and Howley P.M. A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator. Cell 50 (1987) 69-78
132. Lee D., Kim H., Lee Y., and Choe J. Identification of sequence requirement for the origin of DNA replication in human papillomavirus type 18. Virus Res. 52 (1997) 97-108
133. Lee K.Y., Broker T.R., and Chow L.T. Transcription factor YY1 represses cell-free replication from human papillomavirus origins. J. Virol. 72 (1998) 4911-4917
134. Lehman C.W., and Botchan M.R. Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation. Proc. Natl. Acad. Sci. USA 95 (1998) 4338-4343
135. Lentz M.R. A carboxyl-terminal serine of the bovine papillomavirus E1 protein is phosphorylated in vivo and in vitro. Virus Res. 83 (2002) 213-219
136. Lentz M.R., Pak D., Mohr I., and Botchan M.R. The E1 replication protein of bovine papillomavirus type 1 contains an extended nuclear localization signal that includes a p34cdc2 phosphorylation site. J. Virol. 67 (1993) 1414-1423
137. Lentz M.R., Stevens Jr. S.M., Raynes J., and Elkhoury N. A phosphorylation map of the bovine papillomavirus E1 helicase. Virol. J. 3 (2006) 13
138. Li D., Zhao R., Lilyestrom W., Gai D., Zhang R., DeCaprio J.A., Fanning E., Jochimiak A., Szakonyi G., and Chen X.S. Structure of the replicative helicase of the oncoprotein SV40 large tumour antigen. Nature 423 (2003) 512-518
139. Li R., and Botchan M.R. The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication. Cell 73 (1993) 1207-1221
140. Li R., and Botchan M.R. Acidic transcription factors alleviate nucleosome-mediated repression of DNA replication of bovine papillomavirus type 1. Proc. Natl. Acad. Sci. USA 91 (1994) 7051-7055
141. Li R., Knight J., Bream G., Stenlund A., and Botchan M. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV- 1 genome. Genes Dev. 3 (1989) 510-526
142. Lim D.A., Gossen M., Lehman C.W., and Botchan M.R. Competition for DNA binding sites between the short and long forms of E2 dimers underlies repression in bovine papillomavirus type 1 DNA replication control. J. Virol. 72 (1998) 1931-1940
143. Lin B.Y., Ma T., Liu J.S., Kuo S.R., Jin G., Broker T.R., Harper J.W., and Chow L.T. HeLa cells are phenotypically limiting in cyclin E/CDK2 for efficient human papillomavirus DNA replication. J. Biol. Chem. 275 (2000) 6167-6174
144. Liu X., Schuck S., and Stenlund A. Adjacent residues in the E1 initiator beta-hairpin define different roles of the beta-hairpin in Ori melting, helicase loading, and helicase activity. Mol. Cell 25 (2007) 825-837
145. Loo Y.M., and Melendy T. Recruitment of replication protein A by the papillomavirus E1 protein and modulation by single-stranded DNA. J. Virol. 78 (2004) 1605-1615
146. Lu J.Z., Sun Y.N., Rose R.C., Bonnez W., and McCance D.J. Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papillomavirus type 11 origin. J. Virol. 67 (1993) 7131-7139
147. Luo X., Sanford D.G., Bullock P.A., and Bachovchin W.W. Solution structure of the origin DNA-binding domain of SV40 T-antigen. Nat. Struct. Biol. 3 (1996) 1034-1039
148. Lusky M., and Botchan M.R. A bovine papillomavirus type 1-encoded modulator function is dispensable for transient viral replication but is required for establishment of the stable plasmid state. J. Virol. 60 (1986) 729-742
149. Ma T., Zou N., Lin B.Y., Chow L.T., and Harper J.W. Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc. Natl. Acad. Sci. USA 96 (1999) 382-387
150. Mannik A., Piirsoo M., Nordstrom K., Ustav E., Vennstrom B., and Ustav M. Effective generation of transgenic mice by Bovine papillomavirus type 1 based self-replicating plasmid that is maintained as extrachromosomal genetic element in three generations of animals. Plasmid 49 (2003) 193-204
151. Mannik A., Runkorg K., Jaanson N., Ustav M., and Ustav E. Induction of the bovine papillomavirus origin "onion skin"-type DNA replication at high E1 protein concentrations in vivo. J. Virol. 76 (2002) 5835-5845
152. Mansky K.C., Batiza A., and Lambert P.F. Bovine papillomavirus type 1 E1 and simian virus 40 large T antigen share regions of sequence similarity required for multiple functions. J. Virol. 71 (1997) 7600-7608
153. Maruyama T., Farina A., Dey A., Cheong J., Bermudez V.P., Tamura T., Sciortino S., Shuman J., Hurwitz J., and Ozato K. A Mammalian bromodomain protein, Brd4, interacts with replication factor C and inhibits progression to S phase. Mol. Cell Biol. 22 (2002) 6509-6520
154. Masai H., You Z., and Arai K. Control of DNA replication: Regulation and activation of eukaryotic replicative helicase, MCM. IUBMB.Life 57 (2005) 323-335
155. Masterson P.J., Stanley M.A., Lewis A.P., and Romanos M.A. A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J. Virol. 72 (1998) 7407-7419
156. McBride A.A., Dlugosz A., and Baker C.C. Production of infectious BPV-1 virions from cloned viral DNA using an organotypic raft/xenograft technique. Proc. Natl. Acad. Sci. USA 97 (2000) 5534-5539
157. McBride A.A., Bolen J.B., and Howley P.M. Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1. J. Virol. 63 (1989) 5076-5085
158. McBride A.A., and Howley P.M. Bovine papillomavirus with a mutation in the E2 serine 301 phosphorylation site replicates at a high copy number. J. Virol. 65 (1991) 6528-6534
159. McBride A.A., and Myers G. The E2 proteins: An update. In: Myers G., et al. (Ed). Human Papillomaviruses 1997 (1997), Los Alamos National Laboratory, Los Alamos III54-III99
160. McBride A.A., Oliveira J.G., and McPhillips M.G. Partitioning viral genomes in mitosis: Same idea, different targets. Cell Cycle 5 (2006) 1499-1502
161. McMillan N.A., Payne E., Frazer I.H., and Evander M. Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology 261 (1999) 271-279
162. McPhillips M.G., Oliveira J.G., Spindler J.E., Mitra R., and McBride A.A. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 80 (2006) 9530-9543
163. McPhillips M.G., Ozato K., and McBride A.A. Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J. Virol. 79 (2005) 8920-8932
164. McShan G.D., and Wilson V.G. Casein kinase II phosphorylates bovine papillomavirus type 1 E1 in vitro at a conserved motif. J. Gen. Virol. 78 (1997) 171-177
165. McShan G.D., and Wilson V.G. Reconstitution of a functional bovine papillomavirus type 1 origin of replication reveals a modular tripartite replicon with an essential AT-rich element. Virology 237 (1997) 198-208
166. McStay B. Nucleolar dominance: A model for rRNA gene silencing. Genes Dev. 20 (2006) 1207-1214
167. Mechali F., Hsu C.Y., Castro A., Lorca T., and Bonne-Andrea C. Bovine papillomavirus replicative helicase E1 is a target of the ubiquitin ligase APC. J. Virol. 78 (2004) 2615-2619
168. Meinke G., Phelan P., Moine S., Bochkareva E., Bochkarev A., Bullock P.A., and Bohm A. The crystal structure of the SV40 T-antigen origin binding domain in complex with DNA. PLoS.Biol. 5 (2007) e23
169. Melendy T., Sedman J., and Stenlund A. Cellular factors required for papillomavirus DNA replication. J. Virol. 69 (1995) 7857-7867
170. Meyers C., Frattini M.G., Hudson J.B., and Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257 (1992) 971-973
171. Meyers C., Mayer T.J., and Ozbun M.A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71 (1997) 7381-7386
172. Mohr I.J., Clark R., Sun S., Androphy E.J., MacPherson P., and Botchan M.R. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250 (1990) 1694-1699
173. Moody C.A., Fradet-Turcotte A., Archambault J., and Laimins L.A. Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc. Natl. Acad. Sci. USA 104 (2007) 19541-19546
174. Muller F., Seo Y.S., and Hurwitz J. Replication of bovine papillomavirus type 1 origin-containing DNA in crude extracts and with purified proteins. J. Biol. Chem. 269 (1994) 17086-17094
175. Narahari J., Fisk J.C., Melendy T., and Roman A. Interactions of the cellular CCAAT displacement protein and human papillomavirus E2 protein with the viral origin of replication can regulate DNA replication. Virology 350 (2006) 302-311
176. Narajczyk M., Baranska S., Wegrzyn A., and Wegrzyn G. Switch from theta to sigma replication of bacteriophage lambda DNA: Factors involved in the process and a model for its regulation. Mol. Genet. Genomics 278 (2007) 65-74
177. Negorev D., and Maul G.G. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20 (2001) 7234-7242
178. Newhouse C.D., and Silverstein S.J. Orientation of a novel DNA binding site affects human papillomavirus- mediated transcription and replication. J. Virol. 75 (2001) 1722-1735
179. O'Connor M.J., Stunkel W., Koh C.H., Zimmermann H., and Bernard H.U. The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J. Virol. 74 (2000) 401-410
180. O'Connor M.J., Tan S.H., Tan C.H., and Bernard H.U. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J. Virol. 70 (1996) 6529-6539
181. Ohe Y., Zhao D., Saijo N., and Podack E.R. Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer. Hum. Gene Ther. 6 (1995) 325-333
182. Oliveira J.G., Colf L.A., and McBride A.A. Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc. Natl. Acad. Sci. USA 103 (2006) 1047-1052
183. Ozbun M.A., and Meyers C. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology 248 (1998) 218-230
184. Parish J.L., Bean A.M., Park R.B., and Androphy E.J. ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol. Cell 24 (2006) 867-876
185. Park R.B., and Androphy E.J. Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol. 76 (2002) 11359-11364
186. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
187. Pattison S., Skalnik D.G., and Roman A. CCAAT displacement protein, a regulator of differentiation-specific gene expression, binds a negative regulatory element within the 5′ end of the human papillomavirus type 6 long control region. J. Virol. 71 (1997) 2013-2022
188. Peh W.L., Middleton K., Christensen N., Nicholls P., Egawa K., Sotlar K., Brandsma J., Percival A., Lewis J., Liu W.J., and Doorbar J. Life cycle heterogeneity in animal models of human papillomavirus- associated disease. J. Virol. 76 (2002) 10401-10416
189. Penrose K.J., Garcia-Alai M., Prat-Gay G., and McBride A.A. CK2 phosphorylation-induced conformational switch triggers degradation of the papillomavirus E2 protein. J. Biol. Chem. 279 (2004) 22430-22439
190. Penrose K.J., and McBride A.A. Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. J. Virol. 74 (2000) 6031-6038
191. Piirsoo M., Ustav E., Mandel T., Stenlund A., and Ustav M. Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J. 15 (1996) 1-11
192. Pittayakhajortwut D., and Angeletti P.C. Analysis of cis-elements that facilitate extrachromosomal persistence of human papillomavirus genomes. Virology 374 (2008) 304-314
193. Platt G.M., Simpson G.R., Mittnacht S., and Schulz T.F. Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J. Virol. 73 (1999) 9789-9795
194. Poddar A., Reed S.C., McPhillips M.G., and McBride A.A. The Human Papillomavirus Type 8 E2 Tethering Protein Targets the Ribosomal DNA Loci of Host Mitotic Chromosomes (2008) manuscript submitted
195. Rangasamy D., and Wilson V.G. Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein. J. Biol. Chem. 275 (2000) 30487-30495
196. Rangasamy D., Woytek K., Khan S.A., and Wilson V.G. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation. J. Biol. Chem. 275 (2000) 37999-38004
197. Ravnan J.-B., Gilbert G.M., Ten Hagen K.G., and Cohen S.N. Random-choice replication of extrachromosomal bovine papillomavirus (BPV) molecules in heterogeneous clonally-derived BPV-infected cell lines. J. Virol. 66 (1992) 6946-6952
198. Rawlins D.R., Milman G., Hayward S.D., and Hayward G.S. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42 (1985) 859-868
199. Remm M., Brain R., and Jenkins J.R. The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic. Acids. Res. 20 (1992) 6015-6021
200. Riese II D.J., Settleman J., Neary K., and DiMaio D. Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity. J. Virol. 64 (1990) 944-949
201. Rogers S. Shope Papilloma Virus - A passenger in man and its significance to potential control of host genome. Nature 212 (1966) 1220-1222
202. Rosas-Acosta G., and Wilson V.G. Identification of a nuclear export signal sequence for bovine papillomavirus E1 protein. Virology 373 (2008) 149-162
203. Rotenberg M.O., Chow L.T., and Broker T.R. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. Virology 172 (1989) 489-497
204. Russell J., and Botchan M.R. cis-Acting components of human papillomavirus (HPV) DNA replication: Linker substitution analysis of the HPV type 11 origin. J. Virol. 69 (1995) 651-660
205. Sakai H., Yasugi T., Benson J.D., Dowhanick J.J., and Howley P.M. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J. Virol. 70 (1996) 1602-1611
206. Sanders C.M., Sizov D., Seavers P.R., Ortiz-Lombardia M., and Antson A.A. Transcription activator structure reveals redox control of a replication initiation reaction. Nucleic Acids Res. 35 (2007) 3504-3515
207. Sanders C.M., and Stenlund A. Recruitment and loading of the E1 initiator protein: An ATP-dependent process catalysed by a transcription factor. EMBO J. 17 (1998) 7044-7055
208. Sarafi T.R., and McBride A.A. Domains of the BPV-1 E1 replication protein required for origin-specific DNA binding and interaction with the E2 transactivator. Virology 211 (1995) 385-396
209. Sarver N., Gruss P., Law M.F., Khoury G., and Howley P.M. Bovine papilloma virus deoxyribonucleic acid: A novel eucaryotic cloning vector. Mol. Cell. Biol. 1 (1981) 486-496
210. Schaal T.D., Mallet W.G., McMinn D.L., Nguyen N.V., Sopko M.M., John S., and Parekh B.S. Inhibition of human papilloma virus E2 DNA binding protein by covalently linked polyamides. Nucleic Acids Res. 31 (2003) 1282-1291
211. Schepers A., Ritzi M., Bousset K., Kremmer E., Yates J.L., Harwood J., Diffley J.F., and Hammerschmidt W. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J. 20 (2001) 4588-4602
212. Schuck S., and Stenlund A. Assembly of a double hexameric helicase. Mol. Cell 20 (2005) 377-389
213. Schuck S., and Stenlund A. Surface mutagenesis of the bovine papillomavirus E1 DNA binding domain reveals residues required for multiple functions related to DNA replication. J. Virol. 80 (2006) 7491-7499
214. Schweiger M.R., You J., and Howley P.M. Bromodomain protein 4 mediates the papillomavirus e2 transcriptional activation function. J. Virol. 80 (2006) 4276-4285
215. Sears J., Ujihara M., Wong S., Ott C., Middeldorp J., and Aiyar A. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J. Virol. 78 (2004) 11487-11505
216. Sedman J., and Stenlund A. The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities. J. Virol. 72 (1998) 6893-6897
217. Sedman T., Sedman J., and Stenlund A. Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus. J. Virol. 71 (1997) 2887-2896
218. Senechal H., Poirier G.G., Coulombe B., Laimins L.A., and Archambault J. Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 358 (2007) 10-17
219. Shafti-Keramat S., Handisurya A., Kriehuber E., Meneguzzi G., Slupetzky K., and Kirnbauer R. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J. Virol. 77 (2003) 13125-13135
220. Shire K., Ceccarelli D.F., Avolio-Hunter T.M., and Frappier L. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J. Virol. 73 (1999) 2587-2595
221. Si H., Verma S.C., Lampson M., Cai Q., and Robertson E.S. KSHV Encoded LANA can Interact with the Nuclear Mitotic Apparatus Protein to Regulate Genome Maintenance and Segregation. J. Virol. 82 (2008) 6734-6746
222. Sim J., Ozgur S., Lin B.Y., Yu J.H., Broker T.R., Chow L.T., and Griffith J. Remodeling of the human papillomavirus type 11 replication origin into discrete nucleoprotein particles and looped structures by the E2 protein. J. Mol. Biol. 375 (2008) 1165-1177
223. Skiadopoulos M.H., and McBride A.A. Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J. Virol. 72 (1998) 2079-2088
224. Smith J.L., Campos S.K., and Ozbun M.A. Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J. Virol. 81 (2007) 9922-9931
225. Soeda E., Ferran M.C., Baker C.C., and McBride A.A. Repression of HPV16 early region transcription by the E2 protein. Virology 351 (2006) 29-41
226. Stanley M.A., Browne H.M., Appleby M., and Minson A.C. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int. J. Cancer 43 (1989) 672-676
227. Steger G., Schnabel C., and Schmidt H.M. The hinge region of the human papillomavirus type 8 E2 protein activates the human p21(WAF1/CIP1) promoter via interaction with Sp1. J. Gen. Virol. 83 (2002) 503-510
228. Stenlund A. E1 initiator DNA binding specificity is unmasked by selective inhibition of non-specific DNA binding. EMBO J. 22 (2003) 954-963
229. Stubenrauch F., Colbert A.M., and Laimins L.A. Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J. Virol. 72 (1998) 8115-8123
230. Stubenrauch F., Hummel M., Iftner T., and Laimins L.A. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. J. Virol. 74 (2000) 1178-1186
231. Stubenrauch F., Lim H.B., and Laimins L.A. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J. Virol. 72 (1998) 1071-1077
232. Sullivan M., Higuchi T., Katis V.L., and Uhlmann F. Cdc14 phosphatase induces rDNA condensation and resolves cohesin-independent cohesion during budding yeast anaphase. Cell 117 (2004) 471-482
233. Sun Y., Han H., and McCance D.J. Active domains of human papillomavirus type 11 E1 protein for origin replication. J. Gen. Virol. 79 (1998) 1651-1658
234. Sun Y.N., Lu J.Z., and McCance D.J. Mapping of HPV-11 E1 binding site and determination of other important cis elements for replication of the origin. Virology 216 (1996) 219-222
235. Sverdrup F., and Khan S.A. Two E2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA. J. Virol. 69 (1995) 1319-1323
236. Sverdrup F., Sheahan L., and Khan S. Development of human papillomavirus plasmids capable of episomal replication in human cell lines. Gene Ther. 6 (1999) 1317-1321
237. Swindle C.S., Zou N., Van Tine B.A., Shaw G.M., Engler J.A., and Chow L.T. Human papillomavirus DNA replication compartments in a transient DNA replication system. J. Virol. 73 (1999) 1001-1009
238. Tan S.H., Bartsch D., Schwarz E., and Bernard H.U. Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses. J. Virol. 72 (1998) 3610-3622
239. Thain A., Jenkins O., Clarke A.R., and Gaston K. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J. Virol. 70 (1996) 7233-7235
240. Thierry F., and Yaniv M. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J. 6 (1987) 3391-3397
241. Thomas J.T., Hubert W.G., Ruesch M.N., and Laimins L.A. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. USA 96 (1999) 8449-8454
242. Titolo S., Brault K., Majewski J., White P.W., and Archambault J. Characterization of the minimal DNA binding domain of the human papillomavirus e1 helicase: Fluorescence anisotropy studies and characterization of a dimerization-defective mutant protein. J. Virol. 77 (2003) 5178-5191
243. Titolo S., Pelletier A., Pulichino A.M., Brault K., Wardrop E., White P.W., Cordingley M.G., and Archambault J. Identification of domains of the human papillomavirus type 11 E1 helicase involved in oligomerization and binding to the viral origin. J. Virol. 74 (2000) 7349-7361
244. Torres-Rosell J., Machin F., Farmer S., Jarmuz A., Eydmann T., Dalgaard J.Z., and Aragon L. SMC5 and SMC6 genes are required for the segregation of repetitive chromosome regions. Nat. Cell Biol. 7 (2005) 412-419
245. Tsurumi T., Fujita M., and Kudoh A. Latent and lytic Epstein-Barr virus replication strategies. Rev. Med. Virol. 15 (2005) 3-15
246. Ustav E., Ustav M., Szymanski P., and Stenlund A. The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc. Natl. Acad. Sci. USA 90 (1993) 898-902
247. Ustav M., and Stenlund A. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10 (1991) 449-457
248. Ustav M., Ustav E., Szymanski P., and Stenlund A. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 10 (1991) 4321-4329
249. Van Tine B.A., Dao L.D., Wu S.Y., Sonbuchner T.M., Lin B.Y., Zou N., Chiang C.M., Broker T.R., and Chow L.T. Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc. Natl. Acad. Sci. USA 101 (2004) 4030-4035
250. Viejo-Borbolla A., Ottinger M., Bruning E., Burger A., Konig R., Kati E., Sheldon J.A., and Schulz T.F. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J. Virol. 79 (2005) 13618-13629
251. Voitenleitner C., and Botchan M. E1 protein of bovine papillomavirus type 1 interferes with E2 protein- mediated tethering of the viral DNA to mitotic chromosomes. J. Virol. 76 (2002) 3440-3451
252. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
253. Waldenstrom M., Schenstrom K., Sollerbrant K., and Hansson L. Replication of bovine papillomavirus vectors in murine cells. Gene 120 (1992) 175-181
254. Wang Y., Coulombe R., Cameron D.R., Thauvette L., Massariol M.J., Amon L.M., Fink D., Titolo S., Welchner E., Yoakim C., Archambault J., and White P.W. Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor. J. Biol. Chem. 279 (2004) 6976-6985
255. White P.W., Titolo S., Brault K., Thauvette L., Pelletier A., Welchner E., Bourgon L., Doyon L., Ogilvie W.W., Yoakim C., Cordingley M.G., and Archambault J. Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction. J. Biol. Chem. 278 (2003) 26765-26772
256. Winokur P.L., and McBride A.A. The transactivation and DNA binding domains of the BPV-1 E2 protein have different roles in cooperative origin binding with the E1 protein. Virology 221 (1996) 44-53
257. Wise-Draper T.M., and Wells S.I. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci. 13 (2008) 1003-1017
258. Woodworth C.D. HPV innate immunity. Front Biosci. 7 (2002) d2058-d2071
259. Wu H., Ceccarelli D.F., and Frappier L. The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1. EMBO Rep. 1 (2000) 140-144
260. Wu S.Y., Lee A.Y., Hou S.Y., Kemper J.K., Erdjument-Bromage H., Tempst P., and Chiang C.M. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 20 (2006) 2383-2396
261. Yang L., Mohr I., Fouts E., Lim D.A., Nohaile M., and Botchan M. The E1 protein of bovine papillomavirus 1 is an ATP-dependent DNA helicase. Proc. Natl. Acad. Sci. USA 90 (1993) 5086-5090
262. Yates J.L., and Guan N. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65 (1991) 483-488
263. Yates J.L., Warren N., and Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313 (1985) 812-815
264. You J., Croyle J.L., Nishimura A., Ozato K., and Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117 (2004) 349-360
265. You J., Schweiger M.R., and Howley P.M. Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells. J. Virol. 79 (2005) 14956-14961
266. You J., Srinivasan V., Denis G.V., Harrington Jr. W.J., Ballestas M.E., Kaye K.M., and Howley P.M. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J. Virol. 80 (2006) 8909-8919
267. Yu J.H., Lin B.Y., Deng W., Broker T.R., and Chow L.T. Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import. J. Virol. 81 (2007) 5066-5078
268. Yu T., Peng Y.C., and Androphy E.J. Mitotic kinesin-like protein 2 binds and colocalizes with papillomavirus E2 during mitosis. J. Virol. 81 (2007) 1736-1745
269. Zanardi T.A., Stanley C.M., Saville B.M., Spacek S.M., and Lentz M.R. Modulation of bovine papillomavirus DNA replication by phosphorylation of the viral E1 protein. Virology 228 (1997) 1-10
270. Zhang B., Chen W., and Roman A. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc. Natl. Acad. Sci. USA 103 (2006) 437-442
271. Zhang B.Y., Li P., Wang E., Brahmi Z., Dunn K.W., Blum J.S., and Roman A. The E5 protein of human papillornavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology 310 (2003) 100-108
272. Zhao K.N., Sun X.Y., Frazer I.H., and Zhou J. DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1. Virology 243 (1998) 482-491
273. Zheng P.S., Brokaw J., and McBride A.A. Conditional mutations in the mitotic chromosome binding function of the bovine papillomavirus type 1 E2 protein. J. Virol. 79 (2005) 1500-1509
274. Zhou J., Sun X.Y., Stenzel D.J., and Frazer I.H. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185 (1991) 251-257
275. Zobel T., Iftner T., and Stubenrauch F. The papillomavirus E8-E2C protein represses DNA replication from extrachromosomal origins. Mol. Cell Biol. 23 (2003) 8352-8362
276. Zou N., Lin B.Y., Duan F., Lee K.Y., Jin G., Guan R., Yao G., Lefkowitz E.J., Broker T.R., and Chow L.T. The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association. J. Virol. 74 (2000) 3761-3770